Cargando…
Exploring the landscape of immunotherapy approaches in sarcomas
Sarcomas comprise a heterogenous group of malignancies, of more than 100 different entities, arising from mesenchymal tissue, and accounting for 1% of adult malignancies. Surgery, radiotherapy and systemic therapy constitute the therapeutic armamentarium against sarcomas, with surgical excision and...
Autores principales: | Pilavaki, Pampina, Panagi, Myrofora, Arifi, Samia, Jones, Robin L., Stylianopoulos, Triantafyllos, Constantinidou, Anastasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853527/ https://www.ncbi.nlm.nih.gov/pubmed/36686827 http://dx.doi.org/10.3389/fonc.2022.1069963 |
Ejemplares similares
-
Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness
por: Panagi, Myrofora, et al.
Publicado: (2022) -
Editorial: Precision medicine in sarcomas: the road to an effective biomarker-driven-care strategy
por: Arifi, Samia, et al.
Publicado: (2023) -
Osteosarcoma: Current Concepts and Evolutions in Management Principles
por: Pilavaki, Pampina, et al.
Publicado: (2023) -
Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis
por: Kalli, Maria, et al.
Publicado: (2019) -
Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy
por: Mpekris, Fotios, et al.
Publicado: (2022)